Certain surgeries, notably major cardiac, orthopedic, and vascular procedures, are associated with a higher incidence of POCD (9–11). These surgeries typically involve prolonged durations, significant physiological stress, and extensive tissue trauma, all of which contributing to cognitive dysfunction (9–11). For example, cardiac surgeries can lead to cerebral microembolism and hypoperfusion, which directly impact cognitive function (10).

The type of anesthetic agent used significantly influences the development of POCD. General anesthesia, especially with volatile anesthetics, has been linked to higher POCD rates compared to regional anesthesia (12). Volatile anesthetics like isoflurane and sevoflurane have been shown to induce neuroinflammation and apoptosis in animal studies (13). In contrast, regional anesthesia, which limits systemic exposure to anesthetics and reduces overall physiological stress, may offer protective effects against POCD.

Surgery triggers a systemic inflammatory response characterized by the release of pro-inflammatory cytokines, such as IL-1β, IL-6, and TNF-α (14). These cytokines can cross the blood–brain barrier (BBB) and induce neuroinflammation, leading to neuronal damage and cognitive impairment (14). In elderly patients, dysregulated immune systems often result in an exaggerated and prolonged inflammatory response, which is particularly detrimental.

The integrity of the BBB is crucial for maintaining central nervous system homeostasis. Aging and surgical stress can compromise BBB function, increasing its permeability to inflammatory mediators and neurotoxic substances (15). This heightened permeability allows systemic inflammatory cytokines to infiltrate the brain, exacerbating neuroinflammation and contributing to POCD (16).

Genetic factors significantly influence an individual’s risk of developing POCD (17). Polymorphisms in genes related to inflammatory responses, such as the Apolipoprotein E (ApoE) ε4 allele, have been associated with a higher risk of POCD (17). Individuals carrying the ApoE ε4 allele are more prone to neuroinflammatory responses and subsequent cognitive decline post-surgery.

Environmental factors, including lifestyle and pre-existing comorbidities, further affect POCD risk. Lifestyle factors such as physical inactivity, poor diet, and smoking can impair cognitive reserve and exacerbate neuroinflammation (18). Common comorbidities in elderly patients, such as hypertension, diabetes, and cardiovascular diseases, also contribute to a higher risk of POCD (19, 20). These conditions lead to chronic low-grade inflammation, endothelial dysfunction, and cerebrovascular pathology, all of which are detrimental to cognitive health.

The POCD primarily impacts cognitive domains such as memory, attention, and executive functions (3, 21). Memory impairment may present as difficulties in retaining and recalling new information, which can disrupt daily activities and social interactions. Attention deficits are characterized by reduced concentration, difficulty maintaining focus on tasks, and increased susceptibility to distractions. Executive function impairments involve challenges in planning, decision-making, and problem-solving. These cognitive deficits significantly impede a patient’s ability to return to normal life and work activities post-surgery (22).

The onset and duration of POCD symptoms vary. Symptoms typically emerge within days to weeks post-surgery, with the acute phase usually occurring within the first week (23). While many patients experience transient cognitive decline that improves over weeks to months, some individuals may suffer from persistent deficits lasting for years (23). Chronic POCD is particularly concerning, as it can severely impact long-term quality of life and independence.

Diagnosing POCD requires comprehensive neuropsychological testing to evaluate various cognitive domains (10). Standardized tests, such as the Mini-Mental State Examination, Montreal Cognitive Assessment, and specific neuropsychological batteries (e.g., Wechsler Adult Intelligence Scale, Rey Auditory Verbal Learning Test) are employed to assess memory, attention, and executive functions (10, 24). Ideally, baseline cognitive assessments are conducted preoperatively to compare with postoperative scores, enabling the identification of significant cognitive declines.

Biomarkers and imaging studies increasingly support POCD diagnosis. Biomarkers such as elevated inflammatory cytokines (e.g., IL-6, TNF-α) and proteins related to neuronal injury (e.g., S100β, tau protein) in cerebrospinal fluid or blood may indicate neuroinflammation and neuronal damage (14, 25). Neuroimaging techniques, including magnetic resonance imaging (MRI) and positron emission tomography (PET), can reveal structural and functional brain changes associated with cognitive impairment (26). MRI can detect hippocampal atrophy and white matter lesions, while PET scans can show hypometabolism in brain regions involved in cognitive functions.

Differentiating POCD from other cognitive disorders, such as delirium and dementia is critical. Delirium is an acute, fluctuating disturbance of consciousness and cognition, typically occurring shortly after surgery and resolving within days, with prominent fluctuations in attention and awareness (27). Dementia is a progressive, persistent cognitive decline, usually unrelated to surgical events, involving significant impairments in daily functioning over months to years (27).

A thorough clinical evaluation, including detailed patient history, physical examination, and careful review of neuropsychological test results, helps distinguish POCD from these conditions (24). Monitoring cognitive changes over time and assessing potential contributing factors, such as medications, infections, and metabolic disturbances, are essential for accurate diagnosis (27).

In summary, the clinical presentation and diagnosis of POCD involve identifying specific cognitive deficits, assessing their onset and duration, and utilizing neuropsychological tests, biomarkers, and imaging studies. Accurate diagnosis is crucial for distinguishing POCD from other cognitive disorders and for developing targeted interventions to improve patient outcomes and quality of life post-surgery.

Conducting a comprehensive geriatric assessment (CGA) is essential for identifying elderly patients at risk for POCD. The CGA evaluates physical health, cognitive function, emotional status, social support, and functional abilities (28). This holistic assessment allows healthcare providers to pinpoint vulnerabilities and customize preoperative care to address specific needs (28). By establishing baseline cognitive function and overall health status, clinicians can develop personalized care plans to reduce the risk of POCD.

Identifying and addressing modifiable risk factors before surgery can significantly reduce the incidence of POCD. Key risk factors include advanced age, pre-existing cognitive impairment, polypharmacy, and comorbidities such as cardiovascular disease, diabetes, and hypertension (18–20). Preoperative optimization may involve adjusting medications, managing chronic diseases, and correcting nutritional deficiencies. By minimizing these risk factors, healthcare providers can enhance patients’ resilience to surgical stress and improve postoperative outcomes.

Prehabilitation, which encompasses physical exercise, nutritional optimization, and psychological support, can improve patients’ physical and mental resilience pre-surgery (29). Educating patients and their families about POCD, its potential impacts, and preventive measures can enhance engagement in preoperative and postoperative care (30). Empowering patients with knowledge and strategies to manage stress and maintain cognitive health can help reduce anxiety and promote a smoother recovery.

Although there have been advancements in managing POCD, significant challenges and deficiencies remain in clinical practice. A primary challenge is the absence of standardized, evidence-based guidelines for the perioperative management of POCD, resulting in considerable variability in care practices across healthcare settings. This inconsistency can lead to disparate patient outcomes and a lack of consensus on best practices for prevention and treatment (31). Additionally, there is a widespread deficiency in the routine use of CGA and cognitive screening tools during the preoperative phase (32). These tools are crucial for identifying patients at heightened risk of POCD, yet they are often underutilized due to time constraints, resource limitations, or a lack of awareness among healthcare providers. This gap in early assessment can prevent the implementation of tailored interventions that might mitigate the risk of cognitive decline.

The integration of multidisciplinary care remains another significant challenge. Optimal management of POCD requires coordination among anesthesiologists, surgeons, geriatricians, neurologists, and rehabilitation specialists (33). However, the lack of structured collaboration between these disciplines often results in fragmented care and missed opportunities for comprehensive perioperative management. Furthermore, the current reliance on pharmacological interventions without sufficient emphasis on non-pharmacological strategies, such as cognitive training, physical rehabilitation, and patient education, reflects a gap in holistic patient care. Non-pharmacological interventions have demonstrated potential in reducing the incidence and severity of POCD, but their incorporation into standard perioperative protocols is inconsistent.

Addressing these challenges necessitates the development of robust, multidisciplinary guidelines, enhanced training programs for healthcare providers, and the adoption of a more integrative approach that combines both pharmacological and non-pharmacological strategies.

Selecting appropriate anesthetic agents and monitoring anesthesia depth are critical to reducing the risk of POCD. Regional anesthesia is often preferred for elderly patients due to its lower impact on cognitive function (34). When general anesthesia is necessary, agents with shorter half-lives and minimal neurotoxic effects, such as propofol, should be used (34). Continuous monitoring of anesthesia depth using technologies like the bispectral index helps avoid over-sedation and minimizes cognitive side effects (35).

Minimally invasive surgical techniques, such as laparoscopic or robotic-assisted surgery, reduce physiological stress, tissue trauma, and inflammatory response compared to traditional open surgeries (36). These approaches are associated with shorter operative times, reduced postoperative pain, and faster recovery, all of which contribute to a lower risk of POCD (37). By minimizing surgical invasiveness, healthcare providers can improve postoperative cognitive outcomes in elderly patients.

Maintaining stable hemodynamic parameters and optimal blood glucose levels during surgery is crucial for preventing POCD (38, 39). Hypotension, hypoxia, and hyperglycemia can exacerbate neuroinflammation and cognitive decline (38, 39). Close monitoring and timely intervention to maintain adequate cerebral perfusion and oxygenation, along with strict glycemic control, are vital strategies (39). Implementing standardized protocols for perioperative hemodynamic and glycemic management can improve overall surgical outcomes and cognitive function.

Early mobilization and rehabilitation are vital for mitigating POCD (40). Encouraging patients to engage in light physical activities soon after surgery enhances blood circulation, reduces inflammation, and promotes cognitive recovery (40). Structured rehabilitation programs tailored to patients’ capabilities accelerate functional recovery and improve cognitive outcomes (21).

Effective pain management is crucial in preventing delirium and subsequent cognitive decline (41). Multimodal analgesia, combining different pain relief strategies, can minimize opioid use and its cognitive side effects. Additionally, implementing protocols to prevent delirium—such as maintaining a calm and oriented environment, optimizing sleep, and managing sensory deficits—is essential to reduce the risk of POCD (41).

Postoperative cognitive training and support programs can aid patients in recovering cognitive functions and maintaining mental agility. Cognitive exercises, such as memory games, problem-solving tasks, and attention training, stimulate neuroplasticity and enhance cognitive recovery (42). Support programs, including counseling and social engagement activities, provide emotional and social support, contributing to overall well-being and cognitive health (43).

In summary, a multifaceted approach involving preoperative assessment and optimization, intraoperative techniques, and comprehensive postoperative care is essential for preventing and managing POCD in elderly patients. By implementing these strategies, healthcare providers can improve cognitive outcomes and enhance the quality of life for elderly patients undergoing surgery.

The POCD in elderly patients remains a critical concern in surgical outcomes, with numerous clinical studies exploring various interventions to mitigate its occurrence (13, 51–73). These studies range from observational to randomized controlled trials, providing comprehensive insights into the efficacy of different treatments (13, 51–73) (Table 1).

Non-pharmacological interventions such as transcutaneous electrical acupoint stimulation (TEAS) have shown promise in reducing POCD. Wang et al. (51) demonstrated that combining conventional nursing with TEAS significantly reduced POCD by decreasing inflammation and neuronal injury in elderly patients undergoing total knee arthroplasty (TKA). Similarly, Xi et al. (57) found that perioperative TEAS reduced inflammation and POCD while improving cognitive function in elderly gastrointestinal tumor patients. Zhang et al. (63) further supported this by showing that preconditioning with electro-acupuncture (EA) enhanced postoperative cognitive function by mitigating inflammatory reactions and brain injury. However, Olotu et al. (55) noted that delirium preventive measures did not significantly lower POCD rates in older adults undergoing cardiovascular surgery, suggesting that tailored interventions are necessary.

Pharmacological interventions have also been extensively studied. Mi et al. (52) reported that intranasal insulin reduced POCD and alleviated peripheral inflammation in elderly patients with metabolic syndrome undergoing non-cardiac surgery. Takazawa et al. (53) evaluated the neuroprotective potential of minocycline in elderly patients after TKA but found no significant efficacy in preventing POCD. Wang et al. demonstrated that dexmedetomidine (DEX) anesthesia reduced both POCD and inflammation in elderly patients (55) (Table 1). Other studies explored the effects of different pharmacological agents: Lu et al. (62) found that parecoxib sodium pretreatment combined with dexmedetomidine reduced early POCD by improving postoperative analgesia and cerebral oxygen metabolism in elderly patients after shoulder arthroscopy, while Zhu et al. (66) showed that parecoxib sodium reduced POCD occurrence post-TKA by attenuating inflammation and acute postoperative pain. Sun et al. (64) reported that intravenous methoxamine infusion stabilized hemodynamics without increasing POCD during hip-joint replacement surgery. Chen et al. (68) found that intravenous lidocaine was effective in treating early POCD following spine surgery. Sun et al. (70) highlighted the role of dobutamine hydrochloride, which influenced POCD development through the plasma concentration of TNF-α. Chi et al. (65) noted the clinical significance of preoperative scopolamine butylbromide injection in POCD prevention in elderly patients undergoing general anesthesia (GA), and Geng et al. (13) suggested that propofol anesthesia might be preferable for elderly patients undergoing laparoscopic cholecystectomy compared to sevoflurane or isoflurane. Qiao et al. (67) observed higher POCD rates with sevoflurane inhalational anesthesia compared to propofol intravenous maintenance in elderly patients undergoing major surgery. Tang et al. (69) evaluated the impact of inhalational anesthetic on POCD in elderly patients with mild cognitive impairment undergoing radical rectal resection. Li et al. (60) found that propofol showed significant short-term advantages over DEX and midazolam in reducing POCD incidence. Langer et al. (61) concluded that intraoperative hypotension did not correlate with POCD and suggested the need for larger multicenter trials. Rossi et al. (71) suggested that POCD is likely not primarily caused by perioperative anticholinergic medications but rather by other mechanisms. Fujita et al. (72) found comparable incidence rates of early POCD with intravenous remifentanil and epidural ropivacaine in elderly patients undergoing upper abdominal surgery. Cai et al. (73) emphasized the strong association between apolipoprotein E ε4 and POCD, indicating the need for genetic considerations in managing cognitive outcomes post-surgery.

Combined interventions have also been investigated. Yang et al. (56) demonstrated that combined etomidate-ketamine anesthesia improved cognitive function and perioperative ECG stability in elderly patients with rheumatic heart valve disease. Quan et al. (59) showed that BIS-guided deep anesthesia during abdominal surgery reduced short-term POCD and peripheral inflammation. Orhun et al. (58) found that combined general anesthesia and epidural analgesia resulted in similar POCD rates compared to general anesthesia alone but better preserved memory, language, and visuospatial functions due to effective pain control.

These studies collectively underscore the multifaceted approaches to managing POCD in elderly patients. Effective clinical management requires a nuanced understanding of individual patient needs, surgical contexts, and the potential benefits of various interventions, from pharmacological treatments to non-pharmacological techniques like TEAS.

Several best practices have emerged from clinical studies on POCD. First, thorough preoperative cognitive assessments enable early identification of at-risk patients and the development of individualized care plans (74). Second, selecting appropriate anesthetic agents and ensuring adequate intraoperative monitoring can reduce neuroinflammation and cognitive decline (75). Third, early postoperative rehabilitation, including physical and cognitive exercises, is crucial for promoting cognitive recovery (21).

However, there are common pitfalls that must be addressed to improve outcomes. Inadequate preoperative assessments can lead to underestimation of POCD risk, while insufficient intraoperative monitoring may result in preventable cognitive declines. Additionally, delaying postoperative rehabilitation can hinder recovery, emphasizing the need for timely interventions. Avoiding these pitfalls requires adherence to established protocols and continuous evaluation of patient care practices.

A multidisciplinary approach is essential for effectively managing POCD. Insights from various specialties, including anesthesiology, geriatrics, neurology, and physical therapy, contribute to comprehensive care strategies (76). Anesthesiologists can optimize anesthesia plans and monitor intraoperative parameters, while geriatricians provide expertise in managing age-related risk factors (77).

Neurologists assist in diagnosing and differentiating POCD from other cognitive disorders, ensuring accurate treatment (78). Physical therapists design and implement rehabilitation programs tailored to individuals’ needs (79). Collaboration among these specialists fosters a holistic approach, addressing the multifaceted nature of POCD and improving patient outcomes.

This review highlights the significance of POCD management in clinical practice, emphasizing the need for the systematic integration of current evidence into everyday perioperative care (80). One of the main recommendations is the adoption of standardized cognitive screening and comprehensive risk assessment protocols, which are essential for identifying high-risk patients early (80). Implementing these protocols can enable healthcare providers to initiate timely interventions, ultimately reducing the prevalence and severity of POCD and enhancing patient recovery and quality of life. Furthermore, the review underscores the value of leveraging insights from previous clinical experiences to refine management strategies for POCD (81). Evidence suggests that multidisciplinary approaches, involving collaboration among anesthesiologists, geriatricians, surgeons, and neurologists, offer a more robust framework for managing the diverse aspects of POCD. Drawing on past clinical cases and outcomes can help in developing more cohesive and effective care pathways, ensuring that interventions are comprehensive and well-coordinated.

To effectively translate research into clinical practice, it is crucial to develop clear, evidence-based guidelines that detail best practices for POCD prevention and management (82). These guidelines should be complemented by ongoing professional development programs, including training and education for healthcare providers on the latest advancements and practical approaches to POCD care. Disseminating successful case studies and intervention models can also provide practical examples, aiding clinicians in implementing research findings within their own practice settings.

Additionally, the integration of feedback from clinical practice is vital for the continuous improvement of POCD management protocols (83). An iterative approach, in which protocols are regularly reviewed and adjusted based on clinical outcomes and new research, ensures that care strategies remain current and effective. This dynamic process not only helps in addressing any challenges encountered in practice but also supports the evolution of POCD management to better meet the needs of patients. By fostering a culture of evidence-based practice and continuous quality improvement, healthcare providers can enhance the overall standard of care for patients at risk of POCD.

The development of new pharmacological treatments for POCD is a promising area of research (84). Future studies are exploring agents aimed at reducing neuroinflammation, oxidative stress, and neuronal damage associated with surgery. Anti-inflammatory drugs targeting specific cytokines involved in neuroinflammation are a key focus (85). Additionally, neuroprotective agents that support synaptic function, and neuronal survival are being investigated. These include drugs that modulate neurotransmitter systems, antioxidants that counteract oxidative damage, and compounds that enhance neuroplasticity. As our understanding of the molecular pathways involved in POCD deepens, these novel pharmacological interventions could provide targeted and effective treatments.

Non-pharmacological interventions, such as cognitive training and physical exercise, remain vital areas of research (47). Cognitive training programs designed to enhance memory, attention, and executive functions can help improve cognitive resilience and recovery in elderly surgical patients (47). These programs are often personalized to address specific deficits identified in preoperative assessments. Physical exercise, with its benefits on overall brain health and neuroplasticity, is also a key focus (47). Research is ongoing to determine the most effective types and intensities of exercise for supporting cognitive function postoperatively. Combining these non-pharmacological strategies with pharmacological treatments may offer a comprehensive approach to managing POCD.

Enhancing the management of postoperative cognitive dysfunction (POCD) requires a strategic approach to optimizing existing medical protocols and exploring novel research avenues. A primary step in optimizing current protocols involves the standardization of perioperative cognitive assessments, such as CGA and routine cognitive screening tools (86). The standardized use of these assessments can enable early identification of patients at elevated risk for POCD, facilitating the implementation of personalized and targeted preventive strategies.

Improvements in anesthetic management, including the careful selection of anesthetic agents with lower neurotoxic potential and the use of advanced monitoring technologies, can also reduce the risk of POCD (86). Incorporating depth of anesthesia monitoring and cerebral oximetry into standard practice allows for real-time adjustments, thereby minimizing perioperative factors that contribute to cognitive decline (86). Research into refining anesthetic protocols should prioritize agents and techniques that demonstrate a protective effect on cognitive function, especially in vulnerable populations.

Expanding the integration of non-pharmacological interventions, such as cognitive prehabilitation, physical exercise, and early mobilization, into perioperative care protocols is another critical area for optimization (29). These interventions have shown promise in reducing the incidence and severity of POCD but are not yet widely adopted. Future research should aim to establish robust evidence through large-scale clinical trials, which can validate the effectiveness of these strategies and support their incorporation into routine clinical guidelines.

New research directions should focus on the discovery of biomarkers for early detection and risk stratification of POCD, which would facilitate the development of personalized treatment plans. Additionally, exploring the roles of the gut-brain axis, neuroinflammation, and genetic predispositions in POCD could reveal novel therapeutic targets. Understanding these complex interactions may lead to breakthroughs in the prevention and management of POCD, moving beyond conventional approaches to more precise and individualized care.

To advance these efforts, a coordinated, multidisciplinary approach is essential. This includes fostering collaboration among anesthesiologists, surgeons, geriatricians, neurologists, and other specialists involved in perioperative care. Establishing comprehensive, evidence-based guidelines and enhancing the education and training of healthcare providers will be pivotal in translating research findings into clinical practice, ultimately improving patient outcomes in the management of POCD.

Understanding the precise mechanisms underlying POCD is crucial for developing effective interventions (87). Future research should focus on elucidating the molecular and cellular pathways contributing to cognitive decline following surgery. This includes studying the roles of neuroinflammation, blood–brain barrier dysfunction, and genetic susceptibility (87). Advanced neuroimaging techniques and biomarker analyses will be instrumental in these investigations, providing insights into the brain changes associated with POCD. Such mechanistic studies are essential for identifying new therapeutic targets and improving our overall understanding of POCD pathophysiology.

Conducting large-scale clinical trials is essential to validate the efficacy of emerging therapies and interventions for POCD (32). These trials should aim to enroll diverse populations to ensure the generalizability of findings. Key areas of focus include the timing, dosage, and combination of pharmacological and non-pharmacological treatments. Additionally, trials should also investigate the long-term effects of these interventions on cognitive function and quality of life (32). Large-scale studies will provide the robust evidence needed to translate research findings into clinical practice and inform guidelines for POCD management.

Incorporating the latest research findings into clinical practice is crucial for improving the management of POCD (88). This involves updating clinical guidelines and protocols to reflect evidence-based interventions. For instance, standardized preoperative cognitive assessments and tailored perioperative care plans should become routine practice. Clinicians need to stay informed about the latest pharmacological and non-pharmacological treatments and consider these options when planning patient care. Integrating new research findings into clinical practice will require collaboration between researchers and healthcare providers to ensure that advancements are effectively translated into patient care.

Ongoing education and training for healthcare professionals are vital for the successful implementation of new POCD management strategies (89). This includes providing training on using cognitive assessment tools, understanding the mechanisms of POCD, and applying evidence-based interventions. Continuing medical education programs, workshops, and interdisciplinary team meetings can facilitate knowledge transfer and skill development (90). Ensuring that all members of the healthcare team are well-informed about the latest research and best practices will enhance the quality of care for elderly surgical patients and reduce the incidence of POCD.

In summary, the future directions and research in POCD encompass emerging therapies, further mechanistic studies, and the integration of new findings into clinical practice. By focusing on these areas, the medical community can develop more effective strategies to prevent and manage POCD, ultimately improving outcomes and quality of life for elderly patients undergoing surgery.